Dasatinib is a medication used to treat certain types of cancer, particularly chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). The Dasatinib price can vary depending on factors such as the country, healthcare system, and whether the patient is purchasing through insurance or out-of-pocket. Generic versions may offer more affordable alternatives, but prices can still be significant. It’s important for patients to consult with their healthcare providers and explore financial assistance options to manage the cost of Dasatinib effectively.
